Back to mobile site

Stephens Reiterates Overweight Rating on Emerson (EMR) Following NDR

December 16, 2019 6:51 AM EST Send to a Friend
Stephens analyst Rob McCarthy reiterated an Overweight rating and $86.00 price target on Emerson (NYSE: EMR) following an NDR. McCarthy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login